factor 1(IGF-1) that consistently increase plasma levels, without affecting cortisol levels.
Potential treatments currently under development have reduced the levels of these hormones, such as growth hormone deficiency in children or the elderly, and human studies have shown increased muscle and bone mineral density, making it a promising treatment for the frail elderly.It also alters the metabolism of fat in the body, so it may have applications in the treatment of obesity.